J1598 HCPCS Level II code: Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg
J1598 is the HCPCS code for “Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J1598Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg
Short description: Inj glycopyrrolate fres kabi
HCPCS · United States
Medicare details
The indicators CMS publishes with J1598 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jul 1, 2024
Where J1598 sits
- 1J codesDrugs administered other than orally
- 2Active code J1598Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J1598 mean?
J1598 is the HCPCS code for “Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J1598?
CMS lists J1598’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J1598
All J codesJ1577Injection, immune globulin (qivigy), 100 mgJ1580Injection, garamycin, gentamicin, up to 80 mgJ1590Injection, gatifloxacin, 10 mgJ1595Injection, glatiramer acetate, 20 mgJ1596Injection, glycopyrrolate, 0.1 mgJ1597Injection, glycopyrrolate (glyrx-pf), 0.1 mgJ1599Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mgJ1600Injection, gold sodium thiomalate, up to 50 mgJ1602Injection, golimumab, 1 mg, for intravenous useJ1610Injection, glucagon hydrochloride, per 1 mgJ1611Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mgJ1612Injection, glucagon (gvoke), 0.01 mg